Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Antisense-mediated isoform switching of steroid receptor coactivator-1 in the central nucleus of the amygdala of the mouse brain.

Zalachoras I, Grootaers G, van Weert LT, Aubert Y, de Kreij SR, Datson NA, van Roon-Mom WM, Aartsma-Rus A, Meijer OC.

BMC Neurosci. 2013 Jan 7;14:5. doi: 10.1186/1471-2202-14-5.

2.

The function of steroid receptor coactivator-1 in normal tissues and cancer.

Walsh CA, Qin L, Tien JC, Young LS, Xu J.

Int J Biol Sci. 2012;8(4):470-85. doi: 10.7150/ijbs.4125. Epub 2012 Mar 7. Review.

3.

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

Aartsma-Rus A, van Ommen GJ.

RNA. 2007 Oct;13(10):1609-24. Epub 2007 Aug 7. Review.

4.

The therapeutic potential of antisense-mediated exon skipping.

van Ommen GJ, van Deutekom J, Aartsma-Rus A.

Curr Opin Mol Ther. 2008 Apr;10(2):140-9. Review.

PMID:
18386226
5.

New developments in exon skipping and splice modulation therapies for neuromuscular diseases.

Touznik A, Lee JJ, Yokota T.

Expert Opin Biol Ther. 2014 Jun;14(6):809-19. doi: 10.1517/14712598.2014.896335. Epub 2014 Mar 12. Review.

PMID:
24620745
6.

Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.

Echigoya Y, Yokota T.

Nucleic Acid Ther. 2014 Feb;24(1):57-68. doi: 10.1089/nat.2013.0451. Epub 2013 Dec 31. Review.

PMID:
24380394

Supplemental Content

Support Center